Improve Precision Medicine Timelines in Community Oncology Care

Most oncology strategies are shaped by evidence and infrastructure that is built and measured in academic centers. Yet most patients are treated in community oncology settings, where biopsy timing, tissue adequacy, turnaround time for molecular results, payer utilization management and social determinants of health (SDOH) can determine whether precision medicine is delivered consistently.

In this webinar, the featured speakers will translate community oncology realities into clinically grounded insights for life sciences leaders developing oncology therapeutics, diagnostics and evidence strategies.

Using case-based examples and published community data, the discussion will examine how community practices put “precision medicine basics” into action. This includes choosing the right test to answer certain clinical questions. For example, tumor NGS panels vs focused assays; germline testing when hereditary risk is suspected; and circulating tumor DNA (ctDNA)/liquid biopsy when tissue is limited or serial monitoring is useful. It will also cover how practices coordinate ordering and interpretation across multidisciplinary teams and ensure biomarker results lead to treatment action.

Finally, the session will examine why SDOH should be treated not simply as background context but as measurable factors that shape outcomes, access and the feasibility of generating longitudinal evidence in community oncology.

Register for this webinar to learn how a community oncology test-to-treat playbook can strengthen biomarker testing, treatment action and evidence strategies at scale.

Speakers

Kashyap Patel, MD, CEO, Carolina Blood and Cancer Care Associates

Dr. Patel is a practicing Medical Oncologist and is board-certified in Hematology, Oncology and Internal Medicine. He is the Editor-in-Chief of In Practice™ – a newly created multimedia resource devoted to community oncology – and the immediate past President of the Community Oncology Alliance (COA). Dr. Patel held leadership roles with the Association of Community Cancer Centers (ACCC) and has authored and presented more than 130 publications. He is frequently quoted in national media on issues including COVID-19, health disparities, and value-based care. He also serves as an Associate Professor of Medicine and advises payers and public-sector stakeholders on oncology policy, economics, and care delivery, including value-based care initiatives and oncology care model pilots.

Message Presenter

Debra Patt, MD, PhD, MBA, Executive Vice President Policy and Strategy, Texas Oncology

Dr. Debra Patt is a practicing oncologist and breast cancer specialist in Austin, Texas, and an executive vice president of Texas Oncology with responsibilities in healthcare policy and strategic initiatives. She is an active leader in breast cancer and research in healthcare informatics driving digital healthcare tool adoption in clinical practice to improve the patient journey. She is the managing partner for the central Texas, Gulf, and Rio Grande Valley regions in Texas Oncology since 2023. Dr. Patt is the medical director for public policy for The US Oncology Network and has testified before the US Congress and Senate to protect access to care for cancer patients. She has chaired the council on legislation and the cancer committee for the Texas Medical Association. Dr. Patt serves as the current vice president of the Community Oncology Alliance and on the ASCO Board of Directors. She also chairs the Artificial Intelligence Task Force for ASCO and is the liaison for the clinical innovation committee. She lectures medical students and is a professor at Dell Medical School at The University of Texas at Austin.

Message Presenter

Susan Duffy, President, Comms, Amplity

As President of Amplity Comms, Susan leads the creative communications professionals in delivering medical communications, media and strategic marketing solutions to help patients get on and stay on the right therapies. Susan comes to Amplity with 25 + years of biopharma marketing expertise spanning a variety of life sciences companies, channels and therapeutic areas. Susan has supported brands in mature and competitive markets, as well as brands that have defined and established new categories and standards of care. In oncology, she has worked with the Levine Cancer Institute, ASCO and helped launch several noteworthy oncology brands.

Message Presenter

Kristin Siyahian, VP of Branded Channels, Amplity

Kristin is a Communications Leader and Content Strategist serving healthcare communities. For more than 20 years, she has concentrated on connecting multidisciplinary oncology teams and patients to critical, timely information to help improve outcomes through multimedia platforms that leverage key clinical, lifestyle, access and business information. At Amplity, she leads communications and content strategy across the company’s medical communications oncology portfolio, directing the strategy and content for five additional platforms and overseeing the editorial launch of In Practice.

Message Presenter